Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.Journal of Medicinal Chemistry|June 1, 2018
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 TetrahydrofuranylglycineKoushi Hidaka, Tooru Kimura, Rajesh Sankaranarayanan, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 2008
Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerasePamela L Donner, Qinghua Xie, John K Pratt, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitorsDale J Kempf, Jeffrey F Waring, David C Morfitt, et al.Antimicrobial Agents and Chemotherapy|December 25, 2002
Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patientsAnn Hsu, Jeffrey Isaacson, Scott Brun, et al.Journal of Virology|May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.Journal of Medicinal Chemistry|April 8, 2009
Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavirDavid A DeGoey, David J Grampovnik, William J Flosi, et al.Plos Neglected Tropical Diseases|July 10, 2023
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activityNegar Alami, David C Carter, Nisha V Kwatra, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.Antiviral Chemistry & Chemotherapy|July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavirDale J Kempf, Cheri Klein, Hui-Ju Chen, et al.Pageof 8